Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea · Delayed Price · Currency is KRW 1,182,000
-24,000 (-1.99%)
Oct 14, 2026, 3:30 PM KST
Samsung Biologics Stock Forecast
Stock Price Forecast
According to 26 analysts polled by S&P Global, Samsung Biologics stock has a consensus rating of "Buy" and an average price target of ₩1,899,600. The average 1-year stock price forecast is 60.71% higher than the current stock price, while the lowest is ₩1,550,000 (+31.13%) and the highest is ₩2,200,000 (+86.13%).
Price Target: ₩1,899,600 (+60.71%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Samsung Biologics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 13 | 15 | 14 | 15 | 14 |
| Buy | 10 | 10 | 10 | 10 | 10 | 10 |
| Hold | 0 | 0 | 0 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 23 | 25 | 25 | 26 | 26 |
Financial Forecast
Revenue This Year
5.48T
from 4.56T
Increased by 20.30%
Revenue Next Year
6.31T
from 5.48T
Increased by 15.12%
EPS This Year
41.06K
from 26.63K
Increased by 54.18%
EPS Next Year
46.05K
from 41.06K
Increased by 12.16%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.